Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

“Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage”

Authors: Pedro Navarro-Illana, Javier Diez-Domingo, Esther Navarro-Illana, José Tuells, Sara Alemán, Joan Puig-Barberá

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

HPV vaccine coverage is far from ideal in Valencia, Spain, and this could be partially related to the low knowledge about the disease and the vaccine, therefore we assessed these, as well as the attitude towards vaccination in adolescent girls, and tried to identify independently associated factors that could potentially be modified by an intervention in order to increase vaccine coverage.

Methods

A cross sectional study was conducted in a random selection of schools of the Spanish region of Valencia. We asked mothers of 1278 girls, who should have been vaccinated in the 2011 campaign, for informed consent. Those that accepted their daughters’ participation, a questionnaire regarding the Knowledge of HPV infection and vaccine was passed to the girls in the school.

Results

833 mothers (65.1%) accepted participation. All their daughters’ responded the questionnaire. Of those, 89.9% had heard about HPV and they associated it to cervical cancer. Only 14% related it to other problems like genital warts. The knowledge score of the girls who had heard about HPV was 6.1/10. Knowledge was unrelated to the number of contacts with the health system (Pediatrician or nurse), and positively correlated with the discussions with classmates about the vaccine. Adolescents Spanish in origin or with an older sister vaccinated, had higher punctuation. 67% of the girls thought that the vaccine prevented cancer, and 22.6% felt that although prevented cancer the vaccine had important safety problems. 6.4% of the girls rejected the vaccine for safety problems or for not considering themselves at risk of infection. 71.5% of the girls had received at least one vaccine dose. Vaccinated girls scored higher knowledge (p = 0.05).

Conclusion

Knowledge about HPV infection and vaccine was fair in adolescents of Valencia, and is independent to the number of contacts with the health system, it is however correlated to the conversations about the vaccine with their peers and the vaccination status. An action to improve HPV knowledge through health providers might increase vaccine coverage in the adolescents.
Literature
1.
go back to reference Muñoz N, Castellsagué X, de González AB, Gissmann L: HPV in the etiology of human cancer. Vaccine. 2006, 24 (Suppl 3): 1-10.CrossRef Muñoz N, Castellsagué X, de González AB, Gissmann L: HPV in the etiology of human cancer. Vaccine. 2006, 24 (Suppl 3): 1-10.CrossRef
3.
go back to reference Miñarro R, Black R, Martínez C, Navarro C, Garau I, Izarzuguaza I, Arananaz E, Vergara A, Galceran J, Alonso R, Mateos A, Rodriguez M: Cancer Incidence and Mortality in Spain. Patterns and Trends. 2000, International Agency for Research on Cancer: Lyon Miñarro R, Black R, Martínez C, Navarro C, Garau I, Izarzuguaza I, Arananaz E, Vergara A, Galceran J, Alonso R, Mateos A, Rodriguez M: Cancer Incidence and Mortality in Spain. Patterns and Trends. 2000, International Agency for Research on Cancer: Lyon
4.
go back to reference Franco EL, Harper DM: Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine. 2005, 23: 2388-2394. 10.1016/j.vaccine.2005.01.016.CrossRefPubMed Franco EL, Harper DM: Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine. 2005, 23: 2388-2394. 10.1016/j.vaccine.2005.01.016.CrossRefPubMed
5.
go back to reference Harper D, Gall S, Naud P, Quint W: Substained immunogenicity and high efficacy against HPV-16/18 related cervical neoplasia: Long-term follow-up through 6,4 years in women vaccinated with Cervarix (GSK, s HPV 16/18 AS04 candidate vaccine). Gynecol Oncol. 2008, 109: 158-159.CrossRef Harper D, Gall S, Naud P, Quint W: Substained immunogenicity and high efficacy against HPV-16/18 related cervical neoplasia: Long-term follow-up through 6,4 years in women vaccinated with Cervarix (GSK, s HPV 16/18 AS04 candidate vaccine). Gynecol Oncol. 2008, 109: 158-159.CrossRef
6.
go back to reference Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)—16/18 AS04—adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPC types (PATRICIA): Final analysis of a doubled-blind, randomised study in young women. Lancet. 2009, 374: 301-314. 10.1016/S0140-6736(09)61248-4.CrossRefPubMed Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)—16/18 AS04—adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPC types (PATRICIA): Final analysis of a doubled-blind, randomised study in young women. Lancet. 2009, 374: 301-314. 10.1016/S0140-6736(09)61248-4.CrossRefPubMed
7.
go back to reference Joura E, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, et al: HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine. 2008, 26: 6844-6851. 10.1016/j.vaccine.2008.09.073.CrossRefPubMed Joura E, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, et al: HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine. 2008, 26: 6844-6851. 10.1016/j.vaccine.2008.09.073.CrossRefPubMed
8.
go back to reference Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007, 369: 1693-1702. 10.1016/S0140-6736(07)60777-6.CrossRefPubMed Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007, 369: 1693-1702. 10.1016/S0140-6736(07)60777-6.CrossRefPubMed
9.
go back to reference Tuells J, Duro Torrijos JL, Chilet Rosell E, Pastor Villalba E, Portero Alonso A, Navarro Ortiz C, Galiana de la Villa E: Noticias sobre el virus del papiloma humano y su vacuna en la prensa valenciana (2006–2011). Gac Sanit. 2013, 27: 374-377. 10.1016/j.gaceta.2012.12.014.CrossRefPubMed Tuells J, Duro Torrijos JL, Chilet Rosell E, Pastor Villalba E, Portero Alonso A, Navarro Ortiz C, Galiana de la Villa E: Noticias sobre el virus del papiloma humano y su vacuna en la prensa valenciana (2006–2011). Gac Sanit. 2013, 27: 374-377. 10.1016/j.gaceta.2012.12.014.CrossRefPubMed
10.
go back to reference Martínez-González MA, Carlos S, de Irala J: Vacuna contra el virus del papiloma humano: razones para el optimismo y razones para la prudencia. Med Clin (Barc). 2008, 131: 256-263. 10.1016/S0025-7753(08)72246-2.CrossRef Martínez-González MA, Carlos S, de Irala J: Vacuna contra el virus del papiloma humano: razones para el optimismo y razones para la prudencia. Med Clin (Barc). 2008, 131: 256-263. 10.1016/S0025-7753(08)72246-2.CrossRef
11.
go back to reference Navarro-Illana P, Aznar J, Diez-Domingo J: Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics. in press Navarro-Illana P, Aznar J, Diez-Domingo J: Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics. in press
12.
go back to reference Gerend M, Shepherd J: Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women. Women Health. 2011, 1: 25-40.CrossRef Gerend M, Shepherd J: Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women. Women Health. 2011, 1: 25-40.CrossRef
13.
14.
go back to reference Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL: Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012, 30: 3546-3556. 10.1016/j.vaccine.2012.03.063.CrossRefPubMed Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL: Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012, 30: 3546-3556. 10.1016/j.vaccine.2012.03.063.CrossRefPubMed
15.
go back to reference Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD: Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine. 2014, in press Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD: Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine. 2014, in press
16.
go back to reference Kaufman J, Synnot A, Ryan R, Hill S, Horey D, Willis N, Lin V, Robinson P: Face to face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev. 2013, Art. No.: CD010038. doi:10.1002/14651858.CD010038.pub2, 5CrossRef Kaufman J, Synnot A, Ryan R, Hill S, Horey D, Willis N, Lin V, Robinson P: Face to face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev. 2013, Art. No.: CD010038. doi:10.1002/14651858.CD010038.pub2, 5CrossRef
17.
go back to reference Brabin L, Roberts SA, Kitchener HC: A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health. 2007, 7: 20-10.1186/1471-2458-7-20.CrossRefPubMedPubMedCentral Brabin L, Roberts SA, Kitchener HC: A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health. 2007, 7: 20-10.1186/1471-2458-7-20.CrossRefPubMedPubMedCentral
18.
go back to reference de Sanjose S, Cortés X, Méndez C, Puig-Tintore L, Torné A, Roura E, Bosch FX, Castellsague X: Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey. Eur J Obstet Gynecol Reprod Biol. 2008, 140: 234-240. 10.1016/j.ejogrb.2008.04.005.CrossRefPubMed de Sanjose S, Cortés X, Méndez C, Puig-Tintore L, Torné A, Roura E, Bosch FX, Castellsague X: Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey. Eur J Obstet Gynecol Reprod Biol. 2008, 140: 234-240. 10.1016/j.ejogrb.2008.04.005.CrossRefPubMed
19.
go back to reference Bowyer HL, Marlow LA, Hibbitts S, Pollock KG, Waller J: Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine. 2013, 31: 1051-1056. 10.1016/j.vaccine.2012.12.038.CrossRefPubMed Bowyer HL, Marlow LA, Hibbitts S, Pollock KG, Waller J: Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine. 2013, 31: 1051-1056. 10.1016/j.vaccine.2012.12.038.CrossRefPubMed
20.
go back to reference Cabrera de León A, Rodríguez Pérez M, Domínguez Coello S: Validación del modelo REI para medir la clase social en población adulta. Rev Esp Salud Publica. 2009, 83: 231-242.PubMed Cabrera de León A, Rodríguez Pérez M, Domínguez Coello S: Validación del modelo REI para medir la clase social en población adulta. Rev Esp Salud Publica. 2009, 83: 231-242.PubMed
21.
go back to reference Jaworski B, Carey M: Development and psychometric evaluation of a self administered questionnaire to measure knowledge of sexually transmitted diseases. AIDS Behav. 2007, 4: 557-574.CrossRef Jaworski B, Carey M: Development and psychometric evaluation of a self administered questionnaire to measure knowledge of sexually transmitted diseases. AIDS Behav. 2007, 4: 557-574.CrossRef
22.
go back to reference Dempsey A, Cohn L, Dalton V, Ruffin M: Patient and clinic factors associated with adolescente hyman papillomavirus vaccine utilization within a university based health system. Vaccine. 2010, 28: 989-995. 10.1016/j.vaccine.2009.10.133.CrossRefPubMed Dempsey A, Cohn L, Dalton V, Ruffin M: Patient and clinic factors associated with adolescente hyman papillomavirus vaccine utilization within a university based health system. Vaccine. 2010, 28: 989-995. 10.1016/j.vaccine.2009.10.133.CrossRefPubMed
23.
go back to reference Mortensen GL: Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health. 2010, 10: 68-10.1186/1471-2458-10-68.CrossRefPubMedPubMedCentral Mortensen GL: Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health. 2010, 10: 68-10.1186/1471-2458-10-68.CrossRefPubMedPubMedCentral
24.
go back to reference Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR: Missed clinical opportunities: provider recommendations por HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011, 47: 8634-8641.CrossRef Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR: Missed clinical opportunities: provider recommendations por HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011, 47: 8634-8641.CrossRef
25.
go back to reference Bodemer N, Müller SM, Okan Y, Garcia-Retamero R, Neumeyer-Gromen A: Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV. Vaccine. 2012, 25: 3747-3756.CrossRef Bodemer N, Müller SM, Okan Y, Garcia-Retamero R, Neumeyer-Gromen A: Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV. Vaccine. 2012, 25: 3747-3756.CrossRef
26.
go back to reference Mathur M, Mathur V, Reichling D: Participation in the decision to become vaccinated against human papillomavirus by California High School girls and the predictors of vaccine status. J Pediatr Health Care. 2010, 24: 14-24. 10.1016/j.pedhc.2008.11.004.CrossRefPubMed Mathur M, Mathur V, Reichling D: Participation in the decision to become vaccinated against human papillomavirus by California High School girls and the predictors of vaccine status. J Pediatr Health Care. 2010, 24: 14-24. 10.1016/j.pedhc.2008.11.004.CrossRefPubMed
27.
go back to reference Agius PA, Pitts MK, Smith AM, Mitchell A: Human Papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine. 2010, 27: 4416-4422.CrossRef Agius PA, Pitts MK, Smith AM, Mitchell A: Human Papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine. 2010, 27: 4416-4422.CrossRef
28.
go back to reference Caskey R, Lindau S, Alexander G: Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adol Health. 2009, 45: 453-462. 10.1016/j.jadohealth.2009.04.021.CrossRef Caskey R, Lindau S, Alexander G: Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adol Health. 2009, 45: 453-462. 10.1016/j.jadohealth.2009.04.021.CrossRef
29.
go back to reference Wegwartha O, Kurzenhäuser-Carstens S, Gigerenzera G: Overcoming the knowledge–behavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014, 32: 1388-1393. 10.1016/j.vaccine.2013.12.038.CrossRef Wegwartha O, Kurzenhäuser-Carstens S, Gigerenzera G: Overcoming the knowledge–behavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014, 32: 1388-1393. 10.1016/j.vaccine.2013.12.038.CrossRef
30.
go back to reference Noakes K, Yarwood J, Salisbury D: Parental response to the introduction of a vaccine against human papilloma virus. Hum Vaccin. 2006, 2: 243-248. 10.4161/hv.2.6.3391.CrossRefPubMed Noakes K, Yarwood J, Salisbury D: Parental response to the introduction of a vaccine against human papilloma virus. Hum Vaccin. 2006, 2: 243-248. 10.4161/hv.2.6.3391.CrossRefPubMed
31.
go back to reference Javitt G, Berkowitz D, Gostin L: Assessing mandatory HPV vaccination: who should call the shots?. J Law Med Ethics. 2008, 2: 384-395.CrossRef Javitt G, Berkowitz D, Gostin L: Assessing mandatory HPV vaccination: who should call the shots?. J Law Med Ethics. 2008, 2: 384-395.CrossRef
32.
go back to reference Chando S, Tiro JA, Harris TR, Kobrin S, Breen N: Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013, 2: 270-272.CrossRef Chando S, Tiro JA, Harris TR, Kobrin S, Breen N: Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013, 2: 270-272.CrossRef
33.
go back to reference Allena JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD: A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010, 28: 4027-4037. 10.1016/j.vaccine.2010.03.063.CrossRef Allena JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD: A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010, 28: 4027-4037. 10.1016/j.vaccine.2010.03.063.CrossRef
Metadata
Title
“Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage”
Authors
Pedro Navarro-Illana
Javier Diez-Domingo
Esther Navarro-Illana
José Tuells
Sara Alemán
Joan Puig-Barberá
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-490

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue